Financhill
Buy
63

KVUE Quote, Financials, Valuation and Earnings

Last price:
$18.70
Seasonality move :
7.31%
Day range:
$18.53 - $18.80
52-week range:
$14.02 - $25.17
Dividend yield:
4.43%
P/E ratio:
25.13x
P/S ratio:
2.40x
P/B ratio:
3.37x
Volume:
45.4M
Avg. volume:
55.6M
1-year change:
-12.82%
Market cap:
$35.8B
Revenue:
$15.5B
EPS (TTM):
$0.74

Analysts' Opinion

  • Consensus Rating
    Kenvue, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 12 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $18.92, Kenvue, Inc. has an estimated upside of 1.16% from its current price of $18.70.
  • Price Target Downside
    According to analysts, the lowest downside price target is $17.00 representing 100% downside risk from its current price of $18.70.

Fair Value

  • According to the consensus of 13 analysts, Kenvue, Inc. has 1.16% upside to fair value with a price target of $18.92 per share.

KVUE vs. S&P 500

  • Over the past 5 trading days, Kenvue, Inc. has overperformed the S&P 500 by 5.82% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Kenvue, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kenvue, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Kenvue, Inc. reported revenues of $3.8B.

Earnings Growth

  • Kenvue, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Kenvue, Inc. reported earnings per share of $0.21.
Enterprise value:
43.8B
EV / Invested capital:
--
Price / LTM sales:
2.40x
EV / EBIT:
16.04x
EV / Revenue:
2.92x
PEG ratio (5yr expected):
0.73x
EV / Free cash flow:
26.82x
Price / Operating cash flow:
22.06x
Enterprise value / EBITDA:
13.28x
Gross Profit (TTM):
$8.7B
Return On Assets:
5.38%
Net Income Margin (TTM):
9.55%
Return On Equity:
13.85%
Return On Invested Capital:
7.47%
Operating Margin:
18.95%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $15.5B $15.5B $15B $3.9B $3.8B
Gross Profit $8.6B $8.9B $8.7B $2.3B $2.2B
Operating Income $3B $2.8B $2.7B $700M $713M
EBITDA $3.6B $3.4B $3.3B $882M $854M
Diluted EPS $0.92 $0.55 $0.74 $0.20 $0.21
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- $5.5B $5.9B $5.9B $6B
Total Assets -- $26B $27.1B $26.9B $27.2B
Current Liabilities -- $3.9B $5.2B $5.9B $6.2B
Total Liabilities -- $7.1B $16.2B $16.3B $16.6B
Total Equity -- $18.9B $10.9B $10.6B $10.6B
Total Debt -- -- $8.3B $7.1B $7.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2.9B $1.9B $2.1B $249M $294M
Cash From Investing -$390M -$558M -$493M -$56M -$104M
Cash From Financing -$2.2B -$1.4B -$1.6B -$162M -$110M
Free Cash Flow $2.5B $1.4B $1.6B $190M $196M
KVUE
Sector
Market Cap
$35.8B
$105.5M
Price % of 52-Week High
74.3%
75.48%
Dividend Yield
4.43%
0%
Shareholder Yield
5.77%
2.42%
1-Year Price Total Return
-12.82%
-1.16%
Beta (5-Year)
--
0.246
Dividend yield:
4.43%
Annualized payout:
$0.81
Payout ratio:
100.24%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $18.31
200-day SMA
Sell
Level $19.17
Bollinger Bands (100)
Buy
Level 15.77 - 17.67
Chaikin Money Flow
Sell
Level -906.7M
20-day SMA
Buy
Level $17.81
Relative Strength Index (RSI14)
Buy
Level 75.09
ADX Line
Buy
Level 26.17
Williams %R
Sell
Level -14.7092
50-day SMA
Buy
Level $17.38
MACD (12, 26)
Buy
Level 0.36
25-day Aroon Oscillator
Buy
Level 92
On Balance Volume
Neutral
Level 200.8M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.5073)
Buy
CA Score (Annual)
Level (-0.2433)
Buy
Beneish M-Score (Annual)
Level (-2.6224)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.1667)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Stock Forecast FAQ

In the current month, KVUE has received 1 Buy ratings 12 Hold ratings, and 0 Sell ratings. The KVUE average analyst price target in the past 3 months is $18.92.

  • Where Will Kenvue, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kenvue, Inc. share price will rise to $18.92 per share over the next 12 months.

  • What Do Analysts Say About Kenvue, Inc.?

    Analysts are divided on their view about Kenvue, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kenvue, Inc. is a Sell and believe this share price will drop from its current level to $17.00.

  • What Is Kenvue, Inc.'s Price Target?

    The price target for Kenvue, Inc. over the next 1-year time period is forecast to be $18.92 according to 13 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 12 analysts rate the stock a Hold.

  • Is KVUE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kenvue, Inc. is a Hold. 12 of 13 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of KVUE?

    You can purchase shares of Kenvue, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kenvue, Inc. shares.

  • What Is The Kenvue, Inc. Share Price Today?

    Kenvue, Inc. was last trading at $18.70 per share. This represents the most recent stock quote for Kenvue, Inc.. Yesterday, Kenvue, Inc. closed at $18.70 per share.

  • How To Buy Kenvue, Inc. Stock Online?

    In order to purchase Kenvue, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Is Sandisk The Next Big Memory Stock?
Is Sandisk The Next Big Memory Stock?

Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock